News

Brown-Forman Launches Distribution Business in Italy
Brown-Forman Corporation (NYSE:BFA,BFB), one of the largest American-owned spirits companies, today announced the start of ...
Clinical Trials Arena on MSN9d
US FDA approves BlackfinBio’s gene therapy trial for hereditary spastic paraplegia
The US Food and Drug Administration has cleared BlackfinBio's investigational new drug (IND) application for a Phase I/II ...
Health And Pharma9d
New Hope for SPG47: BlackfinBio’s BFB-101 Gene Therapy Advances with FDA Approval
The US FDA has cleared the investigational new drug (IND) application to begin clinical trials for BFB-101, a novel gene ...
Precision Medicine Online9d
BlackfinBio Launching Gene Therapy Trial in Rare Neurological Condition at Boston Children's
The UK-based company will evaluate BFB-101 in up to five children with hereditary spastic paraplegia type 47 in a Phase I/II trial.
BioWorld10d
Blackfinbio’s AAV gene therapy gains IND clearance
Blackfinbio Ltd. has obtained IND clearance from the FDA for its novel AAV gene therapy, BFB-101, for hereditary spastic paraplegia type 47 (SPG47), which is caused by changes in the AP4B1 gene. A ...
ZAWYA29d
Bahrain FinTech Bay Partners with ZenData security to launch specialized cybersecurity training programs
Th<span id="cke_bm_1557E" style="display:no e partnership aims to strengthen cybersecurity awareness and capabilities among professionals, students, and individuals in the financial sector and beyond ...